Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18

Wednesday, March 10, 2010 - 11:35 in Health & Medicine

Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, scientists report.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net